- All regions
- Asia
Hong Kong
India
Japan
Korea, Republic of
Singapore
Taiwan- Australasia
Australia
New Zealand- Europe
Austria
Belgium
Bosnia Herzegovina
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Macedonia
Netherlands
Norway
Poland
Portugal
Romania
Serbia Montenegro
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom- North America
Canada
United States
Top Pharmaceuticals stocks in Korea, Republic of
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
| Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
|---|---|---|---|
 033270Korea United Pharm | KR₩288bn | 4.75 | 2.25% |
| 096760JW Holdings | KR₩288bn | 7.96 | 2.76% |
| 082800Vivozon Pharmaceutical Co | KR₩251bn | n/a | n/a |
| 003220Daewon Pharmaceutical Co | KR₩244bn | n/a | 2.63% |
| 000520Samil Pharmaceutical Co | KR₩238bn | n/a | n/a |
| 115450HLB Therapeutics Co | KR₩237bn | n/a | n/a |
| 271980Jeil Pharmaceutical Co | KR₩232bn | 11.67 | n/a |
| 005500Samjin Pharmaceutical Co | KR₩220bn | 10.53 | 4.24% |
| 086890ISU ABXIS Co | KR₩219bn | 7.03 | n/a |
| 086820Bio Solution Co | KR₩217bn | n/a | n/a |
| 334970Prestige Biologics Co | KR₩214bn | n/a | n/a |
| 307750Kukjeon Pharmaceutical Co | KR₩208bn | n/a | 0.24% |
| 234080JW Life Science | KR₩206bn | 4.32 | 3.77% |
| 102460Reyon Pharmaceutical Co | KR₩201bn | n/a | n/a |
| 131030Optus Pharmaceutical Co | KR₩198bn | 16.1 | n/a |
| 001360Samsung Pharm Co | KR₩188bn | 3.43 | n/a |
| 234690Green Cross WellBeing | KR₩183bn | 20.81 | 1.17% |
| 293480Hana Pharm Co | KR₩180bn | 14.12 | 4.91% |
| 023910Dai Han Pharm Co | KR₩177bn | 5.62 | 2.99% |
| 016580Whanin Pharm Co | KR₩176bn | 11.14 | 2.77% |